FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064453676> ?p ?o ?g. }

• W2064453676 endingPage "310" @default.
• W2064453676 startingPage "299" @default.
• W2064453676 abstract "The antitumor drug NB-506 is a glycosylated indolocarbazole derivative targeting topoisomerase I. This DNA-intercalating agent, which is currently undergoing phase I/II clinical trials, was shown to induce apoptosis in HL-60 human leukemia cells. We compared the cellular dysfunctions induced by NB-506 and the reference topoisomerase I poison camptothecin (CPT) at the nuclear, mitochondrial, and cytoplasmic levels. The two drugs NB-506 and CPT were almost equally toxic to HL-60 cells and produced similar cell cycle changes with a considerable increase in the fraction of cells with DNA content less than G1. The sub-G1 fraction, which can be considered as the apoptotic cell population, appeared more rapidly with CPT than with NB-506 but in both cases, the cell cycle perturbation was accompanied by a marked decrease in the mitochondrial transmembrane potential and the intracellular pH. In contrast, no change in the intracellular calcium concentration was detected. Treatment of HL-60 cells with NB-506 resulted in an increase in the activity of the intracellular protease caspase-3, as determined by a DEVD-based colorimetric assay and direct monitoring of poly(ADP-ribose) polymerase (PARP) cleavage by Western blot analysis. The initiator caspase-8 was also stimulated by NB-506 but, as for caspase-3, the extent of the caspase activation was weaker with NB-506 compared to CPT. With both drugs, the protease activation resulted in DNA degradation, as independently confirmed via the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay and characterization of internucleosomal DNA fragmentation. Collectively, these findings identify some of the molecular events leading to NB-506-induced apoptosis and as such, provide important mechanistic insights into the mode of action of topoisomerase I-targeted indolocarbazole antitumor drugs." @default.
• W2064453676 created "2016-06-24" @default.
• W2064453676 creator A5027191978 @default.
• W2064453676 creator A5048948927 @default.
• W2064453676 creator A5073920505 @default.
• W2064453676 date "2001-02-01" @default.
• W2064453676 modified "2023-10-16" @default.
• W2064453676 title "Apoptotic response of HL-60 human leukemia cells to the antitumor drug NB-506, a glycosylated indolocarbazole inhibitor of topoisomerase 1" @default.
• W2064453676 cites W125349432 @default.
• W2064453676 cites W1572514066 @default.
• W2064453676 cites W1966539065 @default.
• W2064453676 cites W1970253538 @default.
• W2064453676 cites W1977219317 @default.
• W2064453676 cites W1977499961 @default.
• W2064453676 cites W1986785675 @default.
• W2064453676 cites W1988043250 @default.
• W2064453676 cites W1989578301 @default.
• W2064453676 cites W1996180957 @default.
• W2064453676 cites W1996564028 @default.
• W2064453676 cites W1996708349 @default.
• W2064453676 cites W1997707998 @default.
• W2064453676 cites W2008534783 @default.
• W2064453676 cites W2022872365 @default.
• W2064453676 cites W2023461311 @default.
• W2064453676 cites W2023876191 @default.
• W2064453676 cites W2027185482 @default.
• W2064453676 cites W2032038280 @default.
• W2064453676 cites W2033240274 @default.
• W2064453676 cites W2039048150 @default.
• W2064453676 cites W2041421828 @default.
• W2064453676 cites W2043235491 @default.
• W2064453676 cites W2047569768 @default.
• W2064453676 cites W2062388035 @default.
• W2064453676 cites W2063385957 @default.
• W2064453676 cites W2068790232 @default.
• W2064453676 cites W2072858020 @default.
• W2064453676 cites W2075357854 @default.
• W2064453676 cites W2076549897 @default.
• W2064453676 cites W2076807689 @default.
• W2064453676 cites W2083906562 @default.
• W2064453676 cites W2093078549 @default.
• W2064453676 cites W2094533895 @default.
• W2064453676 cites W2104713798 @default.
• W2064453676 cites W2110357545 @default.
• W2064453676 cites W2118068129 @default.
• W2064453676 cites W2131785128 @default.
• W2064453676 cites W2141260882 @default.
• W2064453676 cites W2147357406 @default.
• W2064453676 cites W2149967205 @default.
• W2064453676 cites W2169486888 @default.
• W2064453676 cites W2274550965 @default.
• W2064453676 cites W2410730881 @default.
• W2064453676 cites W2461711455 @default.
• W2064453676 cites W4248552289 @default.
• W2064453676 cites W4320573465 @default.
• W2064453676 cites W9958541 @default.
• W2064453676 doi "https://doi.org/10.1016/s0006-2952(00)00553-0" @default.
• W2064453676 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11172734" @default.
• W2064453676 hasPublicationYear "2001" @default.
• W2064453676 type Work @default.
• W2064453676 sameAs 2064453676 @default.
• W2064453676 citedByCount "17" @default.
• W2064453676 countsByYear W20644536762016 @default.
• W2064453676 countsByYear W20644536762018 @default.
• W2064453676 countsByYear W20644536762022 @default.
• W2064453676 crossrefType "journal-article" @default.
• W2064453676 hasAuthorship W2064453676A5027191978 @default.
• W2064453676 hasAuthorship W2064453676A5048948927 @default.
• W2064453676 hasAuthorship W2064453676A5073920505 @default.
• W2064453676 hasConcept C147897179 @default.
• W2064453676 hasConcept C153911025 @default.
• W2064453676 hasConcept C154113507 @default.
• W2064453676 hasConcept C190283241 @default.
• W2064453676 hasConcept C196795494 @default.
• W2064453676 hasConcept C2779682216 @default.
• W2064453676 hasConcept C31573885 @default.
• W2064453676 hasConcept C43759708 @default.
• W2064453676 hasConcept C552990157 @default.
• W2064453676 hasConcept C55493867 @default.
• W2064453676 hasConcept C79879829 @default.
• W2064453676 hasConcept C86803240 @default.
• W2064453676 hasConceptScore W2064453676C147897179 @default.
• W2064453676 hasConceptScore W2064453676C153911025 @default.
• W2064453676 hasConceptScore W2064453676C154113507 @default.
• W2064453676 hasConceptScore W2064453676C190283241 @default.
• W2064453676 hasConceptScore W2064453676C196795494 @default.
• W2064453676 hasConceptScore W2064453676C2779682216 @default.
• W2064453676 hasConceptScore W2064453676C31573885 @default.
• W2064453676 hasConceptScore W2064453676C43759708 @default.
• W2064453676 hasConceptScore W2064453676C552990157 @default.
• W2064453676 hasConceptScore W2064453676C55493867 @default.
• W2064453676 hasConceptScore W2064453676C79879829 @default.
• W2064453676 hasConceptScore W2064453676C86803240 @default.
• W2064453676 hasIssue "3" @default.
• W2064453676 hasLocation W20644536761 @default.
• W2064453676 hasLocation W20644536762 @default.
• W2064453676 hasOpenAccess W2064453676 @default.
• W2064453676 hasPrimaryLocation W20644536761 @default.

• next